𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Advances in positron emission tomography

✍ Scribed by Marcelo F. Di Carli


Publisher
Springer
Year
2004
Tongue
English
Weight
645 KB
Volume
11
Category
Article
ISSN
1071-3581

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Pilot study of positron emission tomogra
✍ Dr. Salvatore U. Berlangieri; Dr. David M. Brizel; Dr. Richard L. Scher; Dr. Tob πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 623 KB

## Abstract __Background__. Positron emission tomography (PET) provides a noninvasive modality for evaluating the biochemical processes of normal and pathologic tissue. Preliminary reports of F‐18 fluorodeoxyglucose (FDG) PET indicate its potential usefulness in evaluating head and neck tumors. The

Laparoscopic extraperitoneal para-aortic
✍ Pedro T. Ramirez; Anuja Jhingran; Homer A. Macapinlac; Elizabeth D. Euscher; Mar πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 197 KB

## Abstract ## BACKGROUND: Failure to detect metastasis to para‐aortic nodes in patients with locally advanced cervical cancer leads to suboptimal treatment. No previous studies have prospectively compared positron emission tomography (PET)/computed tomography (CT) with laparoscopic extraperitonea

Evaluation of chemotherapy response in p
✍ Val J. Lowe; Frank R. Dunphy; Mark Varvares; Han Kim; Mark Wittry; Cherie H. Dun πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 186 KB πŸ‘ 2 views

## Background: [f-18]fluorodeoxyglucose (fdg)-positron emission tomography (pet) can measure the metabolic activity of tissues; fdg-pet may be able to predict response to chemotherapy by identifying changes in tumor metabolism. measurement of response to treatment may help improve survival in the m

Revisiting the role of positron-emission
✍ Christine G. Gourin; Brian J. Boyce; Hadyn T. Williams; Anne V. Herdman; Paul A. πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 148 KB πŸ‘ 1 views

## Abstract ## Objectives/Hypothesis: Planned neck dissection following chemoradiation (CR) has been advocated in patients with head and neck squamous cell cancer (HNSCC) with advanced nodal disease and a clinical complete response to CR because of the potential for residual occult nodal disease.